Category Archives: Healthcare

Healthcare Press Releases & News distributed via EuropaWire

New Method Traces Pre-existing Resistance in Cancer Cells, Opening Doors for Targeted Therapies

(IN BRIEF) A recent study published in Nature Communications by researchers at the University of Helsinki introduces a groundbreaking methodology called ReSisTrace, designed to identify and trace pre-existing treatment resistance in cancer cells. By labeling cancer cells with genetic barcodes … Read the full press release

NextGen Initiative: Advancing Cardiovascular Healthcare Through AI-Personalized Therapies

(IN BRIEF) The NextGen project, funded by the EU’s Horizon Europe program with €7.6 million, has commenced in Utrecht, the Netherlands. Led by a 21-member consortium including the European Society of Cardiology, the project aims to personalize therapies for patients … Read the full press release

Lensa, един от най-ценените търговци на оптика в Румъния, пристига в България. Първият шоурум е открит в София

(НАКРАТКО) Lensa, известен търговец на оптика в Румъния, разширява присъствието си в региона, откривайки първия си магазин в България, конкретно в София. Магазинът предлага широка гама от очила и слънчеви очила на водещи марки, като Ray Ban, Police, Furla и … Read the full press release

University of Liverpool Appoints New Chair of Oncology to Tackle Rising Cancer Incidence in Liverpool City Region

(IN BRIEF) As World Cancer Day approaches, the University of Liverpool has appointed Professor Tim Maughan as the Chair of Oncology to address the growing cancer incidence in the Liverpool City Region. With a focus on improving outcomes through immunotherapy … Read the full press release

Report Reveals Crisis in Autism Assessment for Children, Urging a ‘Needs-Led’ Approach

(IN BRIEF) A report by the Child of the North initiative, led by the N8 Research Partnership and former Children’s Commissioner Anne Longfield’s Centre for Young Lives think tank, has unveiled a crisis in autism assessments for children, with many … Read the full press release

AF Gruppen Nominated as Contractor for New Rikshospitalet Temporary Facilities in Oslo

(IN BRIEF) AF Gruppen has received a nomination from the South-Eastern Norway Regional Health Authority to serve as the contractor for the construction of temporary office and accommodation facilities at the New Rikshospitalet (Oslo University Hospital) located in Gaustad, Oslo. … Read the full press release

NIDUS-Family Therapy Shows Promise in Helping People with Dementia Achieve Personal Goals

(IN BRIEF) A recent study led by Queen Mary University of London, in collaboration with the University of Exeter, highlights the efficacy of a new therapy called NIDUS-Family in assisting individuals with dementia and their family carers in achieving their … Read the full press release

Acoramidis Shows Positive Results in Japanese Trial for Treating Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)

(IN BRIEF) In a Phase III trial conducted in Japan, acoramidis, an investigational treatment for transthyretin-mediated amyloid cardiomyopathy (ATTR-CM), demonstrated promising high-level results consistent with the global BridgeBio Pharma, Inc. ATTRibute-CM Phase III trial. The trial in Japan aimed to … Read the full press release

The Future of Cancer Detection: Multi-Cancer Blood Tests Raise Hope and Questions

(IN BRIEF) Multi-cancer early detection (MCED) blood tests hold the promise of revolutionizing cancer screening by providing a comprehensive, minimally invasive screening option for multiple types of cancer in a single blood sample. These tests offer the potential to increase … Read the full press release

BASF Announces Leadership Changes in Nutrition and Health Divisions

(IN BRIEF) BASF has announced leadership changes in its Nutrition and Health divisions. Julia Raquet will assume responsibility for the Division Europe, Middle East, and Africa, while Dr. Martin Volland will take charge of the Division Nutrition & Health. These … Read the full press release

Aviva Research Highlights Need for Greater Awareness of Healthy Lifestyles and Cancer Prevention

(IN BRIEF) New research by Aviva reveals that there is still a need to raise awareness about the importance of leading a healthy lifestyle in cancer prevention. Over half of those surveyed hope cancer won’t happen to them, and 20% … Read the full press release

GSK’s Omjjara Receives EU Approval for Myelofibrosis Treatment

(IN BRIEF) GSK has received marketing authorization from the European Commission for Omjjara (momelotinib), an oral inhibitor targeting JAK1/JAK2 and activin A receptor type 1 (ACVR1). Omjjara is the first approved treatment in the EU for disease-related splenomegaly (enlarged spleen) … Read the full press release

GSK Seeks Regulatory Approval to Extend RSV Vaccination to At-Risk Adults Aged 50-59

(IN BRIEF) GSK has submitted a regulatory application to the European Medicines Agency (EMA) to expand the use of its adjuvanted recombinant respiratory syncytial virus (RSV) vaccine to adults aged 50-59 who are at increased risk for RSV disease. The … Read the full press release

Leadership Changes Announced in Merck Family Board Elections

(IN BRIEF) E. Merck KG, representing the Merck family’s interests in Merck KGaA, has disclosed the results of its regular board elections. Johannes Baillou, with 30 years of board experience at E. Merck KG, has been elected as Chairman of … Read the full press release

Merck Launches Digital Hub in Singapore to Drive Healthcare and Semiconductor Innovation

(IN BRIEF) Merck, a leading science and technology company, has inaugurated the Merck Digital Hub in Singapore, its first digital hub outside of the US and Europe. Supported by the Singapore Economic Development Board (EDB), the hub aims to accelerate … Read the full press release

Sanofi’s Dupixent Receives FDA Approval for Pediatric Eosinophilic Esophagitis (EoE) Treatment

(IN BRIEF) The U.S. Food and Drug Administration (FDA) has granted approval for Dupixent® (dupilumab) to treat pediatric patients aged 1 to 11 years, weighing at least 15 kg, who suffer from eosinophilic esophagitis (EoE). Dupixent is now the first … Read the full press release

Access to Community Perinatal Mental Health Teams Reduces Relapse Risk in Women with Severe Mental Illness After Childbirth

(IN BRIEF) New research conducted by the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London, in collaboration with the University of Exeter, the London School of Hygiene & Tropical Medicine, and the University of Liverpool, reveals that … Read the full press release

University of Liverpool’s VISION Group Secures £569k to Improve Visual Impairment Care in Brain Injury and Neurological Conditions

(IN BRIEF) The University of Liverpool’s VISION group, focusing on visual impairment in acquired brain injury and neurological conditions, has received £569,000 in funding from the National Institute for Health and Care Research (NIHR). Led by Professor Fiona Rowe, the … Read the full press release

BioNTech and DualityBio Initiate Phase 3 Trial for HER2-Targeting ADC in Metastatic Breast Cancer

(IN BRIEF) BioNTech and Duality Biologics have announced the commencement of a pivotal Phase 3 trial for BNT323/DB-1303, a next-generation antibody-drug conjugate (ADC) targeting the Human Epidermal Growth Factor Receptor 2 (HER2) in metastatic breast cancer. The trial will enroll … Read the full press release

Japan Approves Voydeya (danicopan), an Innovative Treatment for Paroxysmal Nocturnal Haemoglobinuria (PNH)

(IN BRIEF) The Japanese Ministry of Health, Labour and Welfare (MHLW) has granted approval for Voydeya (danicopan), a groundbreaking oral Factor D inhibitor, for the treatment of paroxysmal nocturnal haemoglobinuria (PNH). Voydeya is indicated in Japan for use in combination … Read the full press release

Basilea’s Antifungal Cresemba Sales in Latin America Trigger Milestone Payment from Partner Knight Therapeutics

(IN BRIEF) Basilea Pharmaceutica Ltd (SIX: BSLN) has announced that its partner Knight Therapeutics Inc. (TSX: GUD) exceeded the sales threshold for the antifungal Cresemba (isavuconazole) in Latin America in 2023, triggering the first sales milestone payment for the region. … Read the full press release

University of Helsinki Study: Advancing Colorectal Cancer Risk Assessment with Comprehensive Genetic Information

(IN BRIEF) A study led by researchers at the University of Helsinki highlights the need for a more comprehensive approach to assessing the hereditary risk of colorectal cancer. By analyzing genetic data and health records of over 450,000 Finns, the … Read the full press release

Accenture Report Urges Business Leaders to Scale Generative AI by Redesigning Processes and Prioritizing Worker Well-Being

(IN BRIEF) Accenture’s latest report, “Work, workforce, workers: Reinvented in the age of generative AI,” emphasizes the need for business leaders to expand their focus beyond the impact of generative AI on specific tasks and roles. Instead, they should concentrate … Read the full press release

EQT Life Sciences and Gimv Lead €30M Series C Round for Onera Health to Advance Sleep Diagnostics

(IN BRIEF) Onera Health, a leader in sleep diagnostic and monitoring solutions, has successfully completed a €30 million ($32 million) Series C financing round. The funding was led by EQT Life Sciences and co-led by Gimv, with participation from existing … Read the full press release

Empa Researchers Develop Nanoparticle Soldering for Minimally Invasive Surgery

(IN BRIEF) Empa researchers have developed an innovative technique using nanoparticles for soldering wounds, potentially revolutionizing wound closure methods. This groundbreaking approach offers precise temperature control and can be applied in minimally invasive surgery. The nanoparticles enable gentle laser soldering, … Read the full press release

Prudential Appoints Arjan Toor as CEO Health to Drive Transformation and Customer Trust

(IN BRIEF) Prudential plc has announced the appointment of Arjan Toor as its new CEO Health, effective from February 1, 2024. This appointment is a significant step in Prudential’s strategic transformation, focusing on its Health business as one of its … Read the full press release

New Research Reveals Link Between High Blood Sugar and Upper Limb Problems

(IN BRIEF) A recent study led by the University of Exeter has identified a connection between consistently high blood sugar levels and upper limb conditions such as frozen shoulder, Dupuytren’s disease, carpal tunnel syndrome, and trigger finger. The research, conducted … Read the full press release

Basilea Pharmaceutica Acquires Novel Antibiotics Program Targeting Multidrug-Resistant Gram-Negative Bacteria

(IN BRIEF) Basilea Pharmaceutica Ltd (SIX: BSLN), a biopharmaceutical company specializing in severe bacterial and fungal infection treatments, has announced an asset purchase agreement with Spexis AG (SIX: SPEX) for a preclinical antibiotics program aimed at combating Gram-negative bacteria, including … Read the full press release

University of Exeter Receives Multiple Athena Swan Awards for Gender Equality Commitment

(IN BRIEF) The University of Exeter has received recognition for its dedication to gender equality across various departments in the latest Athena Swan Charter Awards round. Five departments, including Health and Care Professions, University of Exeter Medical School, Ecology and … Read the full press release

EQT Launches Healthcare Growth Strategy and Announces First Investment in Mabtech

(IN BRIEF) EQT has unveiled its EQT Healthcare Growth Strategy and revealed its initial investment in Mabtech, acquired from the IK Small Cap II Fund. The strategy aims to capitalize on long-term healthcare trends, leveraging scientific breakthroughs, technology advancements, and … Read the full press release

Accenture Ventures Invests in QuantHealth to Accelerate AI-Powered Clinical Trial Design

(IN BRIEF) Accenture has announced a strategic investment through Accenture Ventures in QuantHealth, an AI-powered clinical trial design company specializing in cloud-based simulations for pharmaceutical and biotech companies. Using AI technology trained on extensive patient data and clinical trial information, … Read the full press release

Gut Microbiome Composition Linked to Reduced Risk of Graft Versus Host Disease After Stem Cell Transplantation

(IN BRIEF) Researchers from the Technical University of Munich (TUM) and the Universitätsklinikum Regensburg (UKR) have discovered that certain microbes in the gut can significantly reduce the occurrence of graft versus host disease (GvHD) following stem cell transplantation. By analyzing … Read the full press release

Merck KGaA Partners with Inspirna to Advance Novel Therapy for RAS-mutated Colorectal Cancer

(IN BRIEF) Merck KGaA, Darmstadt, Germany, has entered into a licensing agreement with Inspirna, Inc. for ompenaclid (RGX-202), a first-in-class oral inhibitor of the creatine transport channel SLC6A8, and SLC6A8-targeting follow-on compounds, currently under Phase II evaluation for the second-line … Read the full press release

Novo Nordisk Initiates Groundbreaking Collaborations for Innovative Obesity and MASH Treatments

(IN BRIEF) Novo Nordisk has announced separate research collaborations with Omega Therapeutics and Cellarity Inc. to explore innovative treatment approaches for obesity and MASH (Metabolic Associated Fatty Liver Disease). The collaboration with Omega aims to develop an epigenomic controller to … Read the full press release

Revolutionary AcuPebble Diagnostic Device Aims to Transform Sleep Apnoea Diagnosis

(IN BRIEF) Researchers at the University of Warwick, in collaboration with other institutions and charities, are leading a groundbreaking initiative to improve the diagnosis and treatment of Obstructive Sleep Apnoea (OSA). OSA often goes undiagnosed, leading to sleep disturbances and … Read the full press release

QIAGEN Expands Presence in Middle East with New Riyadh HQ, MoU with Saudi Ministry of Health, and Oman TB Screening Initiative

(IN BRIEF) QIAGEN, a leading provider of molecular diagnostics and life sciences solutions, is significantly expanding its operations in the Middle East region. In early 2024, the company will open its regional headquarters in Riyadh, Saudi Arabia, to strengthen its … Read the full press release

Nordic Investment Bank and Wellbeing Services County Collaborate on €70 Million Hospital Expansion in Finland

(IN BRIEF) The Nordic Investment Bank (NIB) has entered into a 20-year EUR 70 million loan agreement with the Wellbeing Services County (WSC) of North Savo, Finland, to fund the expansion and renovation of the “Uusi Sydän” central hospital and … Read the full press release

AstraZeneca Advances in Cell Therapy with Acquisition of Gracell Biotechnologies

(IN BRIEF) AstraZeneca has announced its definitive agreement to acquire Gracell Biotechnologies Inc. (NASDAQ: GRCL), a global biopharmaceutical company specializing in cell therapies for cancer and autoimmune diseases. This strategic move aims to bolster AstraZeneca’s presence in the field of … Read the full press release

EIB Invests €12.5 Million in Swedish Medical Startup BrainCool AB to Advance Innovative Cooling Technologies

(IN BRIEF) The European Investment Bank (EIB) has signed a €12.5 million venture debt agreement with Swedish medical company BrainCool AB, specializing in medical cooling solutions. BrainCool is pioneering body cooling technologies that have the potential to revolutionize care standards … Read the full press release

Sanofi Ceases Development of Tusamitamab Ravtansine for NSCLC after Trial Misses Primary Endpoint

(IN BRIEF) Sanofi has announced the discontinuation of the global clinical development program for tusamitamab ravtansine, following an interim analysis of the Phase 3 CARMEN-LC03 trial. The trial assessed tusamitamab ravtansine as a monotherapy in previously treated metastatic non-squamous non-small … Read the full press release